Once Again, Texas Leads the Way

Houston team claims progress on 2 anti-cancer vaccines | Top stories | Chron.com - Houston Chronicle: "Houston scientists are at the forefront of newfound success with therapeutic cancer vaccines, a holy grail of treatment fraught with disappointment during decades of clinical trials.

At a cancer conference Sunday, University of Texas M.D. Anderson Cancer Center researchers presented data from two late-stage trials demonstrating that injections that stimulate the immune system to attack tumors benefitted patients with lymphoma and advanced melanoma, two deadly cancers with limited treatment options.

“These results should open the door for more work with vaccines, for both blood cancers and solid tumors,” said Dr. Larry Kwak, chairman of M.D. Anderson’s department of lymphoma and myeloma and the lymphoma trial’s principal investigator. “We’re finally at the point where the promise is beginning to be realized.”"